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Dosimetry Calculations of Radiopharmaceuticals
Abstract
The goal of this project is to determine the absorbed dose of radiation to a patient using 99mTc-MAA as a
tracer for a lung scan using the MIRD formula accounting only for the radiation dose contributed by the target
organ. The radiation dose for other organs to the target organ is considered negligible as the uptake of 99mTc-
MAA from other organs is less than 1%. In addition to calculating the absorbed dose of radiation, the initial
dose rate was also calculated by back solving to determine the total mass of the lungs. The radiation dose to
the patient by the target organ was calculated to be 269.44 mrads and the initial dose rate was determined to
be 156 mrads/hr.
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This article is available in Undergraduate Journal of Mathematical Modeling: One + Two: https://scholarcommons.usf.edu/ujmm/
vol3/iss1/19
2 KELBE JAHNKE 
 
TABLE OF CONTENTS 
 
Problem Statement ................................................................................................................... 3 
Motivation ................................................................................................................................... 3 
Mathematical Description and Solution Approach .................................................... 4 
Discussion ................................................................................................................................... 6 
Conclusion and Recommendations ................................................................................... 6 
Nomenclature ............................................................................................................................. 7 
References ................................................................................................................................... 8 
Appendix: Tables ..................................................................................................................... 9 
 
  
Jahnke: Dosimetry Calculations of Radiopharmaceuticals
Produced by The Berkeley Electronic Press, 2010
 DOSIMETRY CALCULATIONS OF RADIOPHARMACEUTICALS 3 
 
PROBLEM STATEMENT 
Calculate the absorbed dose to the lungs of an adult patient who received      (      ) 
99m
Tc-MAA, assuming     uptake and uniform distribution of the radioactivity in the lungs. 
Pertinent data are:           and          
   
   
        
        
  
       
. (Saha 199) 
1. Calculate the absorbed dose of radiation from the target organ. 
2. Calculate the initial dose rate. 
MOTIVATION 
The calculation of absorbed radiation is crucial for the safety of both the patient and the 
nuclear medical technician. Radiation overdose risks include vomiting, damage to the 
hematopoietic system, and death (Saha 199). These risks associated with the stages and dose 
ranges are outlined in Table 1 in the Appendix. Radiopharmaceuticals have multiple uses. They 
can be used as tracers for Positron Emission Tomography (PET), studies to determine factors 
such as certain metabolisms, and absorption and as treatment for certain diseases and conditions. 
The problem listed above would be a typical dose to a male patient undergoing a PET scan of the 
lungs to detect a pulmonary embolism. However, the hand calculation of radiation dosing has 
become essentially obsolete due to the use of computer programs that account for additional 
variables that differ from patient to patient.  
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MATHEMATICAL DESCRIPTION AND SOLUTION APPROACH 
The Medical Internal Radiation Dose (MIRD) formula is an equation that can be used to 
determine the dose of radiation to a patient using physical and biological factors such as the 
radioactivity of the source, the source’s effective half-life, target organ mass, as well as many 
other factors determined by the Society of Nuclear Medicine. The effective half-life    of the 
99m
Tc source must first be calculated to determine the dose formula. This is done by considering 
that the effective decay constant is given by         , where    and    are the physical and 
biological decay constants respectively. Since any decay-constant is equal to the factor     times 
the reciprocal of the half-life, the effective decay constant formula may be rewritten as 
          
 
  
 
 
  
 
 
  
. (1) 
The physical half-life of 
99m
Tc is            and the proposed biological half-life of the 
99m
Tc 
source is             . This gives an effective half-life    for the 
99m
Tc source of       . 
Next, the dose rate is given in units of        as 
        (
 
 
)      (   ), (2) 
where    is the absorbed fraction of radiation from the source organ   to the target organ   and 
the value      is a conversion factor so that equation (2) is will be expressed in       . Since 
the equilibrium dose is given by             equation (2) becomes 
    (
 
 
)     (   ). (3) 
Due to physical and biological decay of the radioactivity  , the dose rate will decrease 
accordingly. Supposing that   decays at an exponential rate, equation (3) may be rewritten as  
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    (
   
    
 
)    (   ), (4) 
where    is the radioactivity in the target organ. To obtain the dose of radiation absorbed, 
equation (4) is integrated over the interval       giving 
   
        
  
 
    (   ) ∫  
    
 
 
        
 
  
  
 
    (   ). (5) 
Because the effective decay constant is related to the effective half-life by 
 
  
 
  
   
        , 
equation (5) becomes 
   
            
  
 
     (   ). (6) 
The sum of all the products of the equilibrium dose    and the absorbed fraction    is takes into 
account the multiple types of radiation that a radionuclide may give off. Thus total radiation dose 
is expressed as 
           
  
 
   [ ∑   
 
     (   ) ]. (7) 
Results for the major radiation types that 
99m
Tc releases can be found in Table 2. After the sum 
has been determined,  ̃ can be substituted for          , and   for 
 
 
∑   
 
     , finally giving 
       ̃  . (8) 
The values of   ̃                and             
   
    
  yield a dose of             . 
Now the mass of the lungs must be found to determine the dose rate. This is done by 
using the calculations of Table 2 in the Appendix and exploiting the fact that  
 
∑   
 
        
         
   
    
, i.e.,            . After substituting all values into equation (4), the initial 
dose rate is determined to be            . 
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DISCUSSION 
 The MIRD formula has improved the accuracy of dosimetry calculations by reducing the 
number of assumptions needed to perform dosimetry calculations as opposed to the classic 
method of dosimetry (Early 90). However, the MIRD formula has proved to be limited by other 
factors. One of these limitations is the coefficient of variation, “This is a statistical limitation. A 
coefficient of variation of     or greater represents a considerable uncertainty in the estimate of 
the absorbed fraction” (Early 90). Other limitations include biological calculation factors such as 
the kidney model not being divided into cortex and medulla, the bladder and stomach being a 
fixed size, (Early 90) and the fact that the MIRD formula presupposes that the source is 
uniformly distributed within a standard-sized organ, which is subject to much patient variation” 
(Early 92). It is imperative that these factors are taken into account, and that the dosimetrist be 
knowledgeable of the assumptions and limitations (Early 92). With the invention of more 
powerful computers and additional formulas to take limitations such as the coefficient of 
variation, organ size and shape, and the uniform distribution of the radionuclide dosimetry, 
calculations have become far more accurate than the MIRD formula used in this project. 
CONCLUSION AND RECOMMENDATIONS 
 The project was successful in the calculation of the absorbed dose of radiation from the 
target organ and the initial dose rate. The calculated dose of radiation was             and 
the calculated initial dose rate was            . This problem however, does not account for 
other dose contributions from other source organs to the target organ, and only accounts for the 
dose contribution of the target organ to itself. These additional dose contributions would have 
proved negligible as the remaining    of uptake would have been distributed among the organs 
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in which 
99m
Tc-MAA implants. These organs would have included the kidneys, liver, ovaries or 
testes, and the whole body. Although negligible in this project, future projects could account for 
these additional dose contributions from organs other than the target organ. 
NOMENCLATURE 
Symbol Description Value/Unit 
  Time Hours (  ) 
   Effective half-life        
   Physical half-life      
   Biological half-life        
  Radioactivity Micro-Curie (   ) 
   Radioactivity in target organ           
 ̃                        
  
 
 
∑  
 
   
          
  
   
    
 
  Mass of target organ            
   
Fraction of quanta emitted per disintegration for the 
 th radiation 
- 
   Energy of the emitted quanta for the  th radiation Mega electron volts (   ) 
  (   ) 
Absorbed Fraction from source organ ( ) to target 
organ ( ) for the  th radiation 
- 
   Equilibrium Dose for the  th radiation 
       
        
 
   Effective decay constant        
   Cumulative radiation dose for the  th radiation     
  Total radiation dose     
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Symbol Name / Unit Conversion 
Ci Curie / Radioactivity 
             
(                          ) 
Bq 
Becquerel / 
Radioactivity 
              
MeV 
Million electron volts / 
Energy 
              
rad Rad / Energy           
Gy Gray / Energy         
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APPENDIX: TABLES 
Stage 
Dose Range 
     (  ) 
Symptoms 
1 0-200 (0-2) Usually unobservable 
2 150-400 (1.5-4) 
Transient nausea and vomiting; some 
evidence of damage to hematopoietic 
system, recovering in 1 to 2 months 
3 350-600 (3.5-6) 
Severe damage to hematopoietic 
system; bone marrow transplant 
essential; survival chances, moderate 
4 550-1000 (5.5-10) 
Gastrointestinal damage; severe 
nausea, vomiting and diarrhea; very 
small chance of recovery; death 
follows in 10-24 days 
5 1000 and above (10 and higher) 
Confusion, shock, burning sensation; 
death follows within hours 
Table 1:  Stages of radiation overdose with corresponding dose ranges and symptoms from 
Ref. (Early). 
 
Radiation            
        photon                     
X rays (      )                     
Electrons                     
Total (
       
    
) :         
Table 2:  Major forms of radiation associated with 
99m
Tc-MAA and their 
associated equilibrium dose and absorbed fraction from Ref. (Saha). 
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